EQV EV [ ] E d+ EQV = = 1 ( 1+ r ) Clean Surplus Concep) BVE = BVE 1 + NI RI NI r BVE = 1 d EQV BVE + E [ RI+ ] ( + r ) = BVE lm = 0 ( 1 r ) + +
|
|
- えいしろう つまがみ
- 7 years ago
- Views:
Transcription
1 2005 Ohlson
2 EQV EV [ ] E d+ EQV = = 1 ( 1+ r ) Clean Surplus Concep) BVE = BVE 1 + NI RI NI r BVE = 1 d EQV BVE + E [ RI+ ] ( + r ) = BVE lm = 0 ( 1 r ) + +
3 RIV EVA FCF = EBIT (1 T ) + Dep CapX [ ] E FCF + EV = = 1 1+ R = NOPAT R BVT 1 ( ) EV = BVT + E [ EVA + ] ( + R ) = EV = BVT + MVA ( 1 R ) WC BVT lm = 0 + +
4 EBIT ( 1 T ) = NOPAT
5 1995 RI, = ω RI 1 + ν 1 + ε1 = γν 1 ε 2, ν + EQV BVE + EQV = α1 RI + α 2 Frankle and Lee 1998V/P ν ( ϕni d ) + ( 1 κ ) BVE + α ν κ 2 BVE ω = 0 ν = 0 RI BVE + = 1 ( 1 + r) ω = 1 ν = 0 RI ω = 1, γ = 0 f 1 BVE + = 1 ( 1 + r) ω = 0, γ = 1 ωri + 1 BVE r ν = 0 ( ) = 1 BVE + BVE + = ω0 + ω1ri + ( 1+ r) ω0 + ω1ri 1 ( 1+ r) ν = ω 0 0 γ 1 -
6 - P1 = b0 + b1 BPS + ε P2 = b0 + b1 BPS + b2 RI + ε P3 P4 P5 P6 = b0 + b1 BPS + b2ri f 1 = b0 + b1 BPS + b2 EPS + ε + ε = b0 + b1 BPS + b2eps f + ε = b0 + b1 BPS + b2eps + b3 EPS f + ε - P3
7 Collns e al.(1997) relevance P R 2
8 EVA 税 営 NOPAT WACC ROIWACC
9 - ( ) k p = λ cov CF, R m = CF - CF CF - -
10 ( ) 1+ r (1 + r k ) k = 1
11
12
13
第85 回日本感染症学会総会学術集会後抄録(III)
β β α α α µ µ µ µ α α α α γ αβ α γ α α γ α γ µ µ β β β β β β β β β µ β α µ µ µ β β µ µ µ µ µ µ γ γ γ γ γ γ µ α β γ β β µ µ µ µ µ β β µ β β µ α β β µ µµ β µ µ µ µ µ µ λ µ µ β µ µ µ µ µ µ µ µ
More information第86回日本感染症学会総会学術集会後抄録(II)
χ μ μ μ μ β β μ μ μ μ β μ μ μ β β β α β β β λ Ι β μ μ β Δ Δ Δ Δ Δ μ μ α φ φ φ α γ φ φ γ φ φ γ γδ φ γδ γ φ φ φ φ φ φ φ φ φ φ φ φ φ α γ γ γ α α α α α γ γ γ γ γ γ γ α γ α γ γ μ μ κ κ α α α β α
More information~ ~.86 ~.02 ~.08 ~.01 ~.01 ~.1 6 ~.1 3 ~.01 ~.ω ~.09 ~.1 7 ~.05 ~.03 ~.01 ~.23 ~.1 6 ~.01 ~.1 2 ~.03 ~.04 ~.01 ~.1 0 ~.1 5 ~.ω ~.02 ~.29 ~.01 ~.01 ~.11 ~.03 ~.02 ~.ω 本 ~.02 ~.1 7 ~.1 4 ~.02 ~.21 ~.I
More informationPowerPoint プレゼンテーション
200831012 200810-12 200810-12 200710-12 669 749 700 7.0 % 70 116 99 16.5 % 599 633 600 5.4 % 331 331 312 6.0 % 328 328 308 6.5 % 191 191 171 11.4 % EPS 322 322 283 13.6 % 5,928 5,928 6,048-2.0 % EPS
More information一般演題(ポスター)
6 5 13 : 00 14 : 00 A μ 13 : 00 14 : 00 A β β β 13 : 00 14 : 00 A 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A β 13 : 00 14 : 00 A 13 : 00 14 : 00 A
More informationP-12 P-13 3 4 28 16 00 17 30 P-14 P-15 P-16 4 14 29 17 00 18 30 P-17 P-18 P-19 P-20 P-21 P-22
1 14 28 16 00 17 30 P-1 P-2 P-3 P-4 P-5 2 24 29 17 00 18 30 P-6 P-7 P-8 P-9 P-10 P-11 P-12 P-13 3 4 28 16 00 17 30 P-14 P-15 P-16 4 14 29 17 00 18 30 P-17 P-18 P-19 P-20 P-21 P-22 5 24 28 16 00 17 30 P-23
More information受賞講演要旨2012cs3
アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート アハ ート α β α α α α α
More information⑤香取 徹.indd
77 割引現在価値モデルの理論と有効性 Theory and Efficiency of Discounted Present Value Model Toru Katori FCF EVA FCF EVA RI 1 はじめに 1980 Free Cash Flow: FCF Copeland et. Al 19901990 Economic Value Added: EVA Stewart 1991
More information(1)2004年度 日本地理
1 2 3 4 1 2 3 4 5 6 7 8 9 10 11 12-5.0-5.1-1.4 4.2 8.6 12.4 16.9 19.5 16.6 10.8 3.3-2.0 6.6 16.6 16.6 18.6 21.3 23.8 26.6 28.5 28.2 27.2 24.9 21.7 18.4 22.7 5 1 2 3 4 5 6 7 8 9 10 11 12 2.2 3.5 7.7 11.1
More informationPage
Page Page 1 M&A M&A 1 CFO 3 M&A M&A 1-1 2 M&A M&A M&A M&A 1 BS 1-1 M&A 2 M&A 4 2 PLAN-DO-SEE PLAN-DO-SEE 1-2 SEE PLAN DO 5 Coffee Break M&A FMV Fair Market Value C PLAN-DO-SEE 6 2 2-1 2-1 7 t M&A DCF 2-2
More information日本糖尿病学会誌第58巻第2号
β γ Δ Δ β β β l l l l μ l l μ l l l l α l l l ω l Δ l l Δ Δ l l l l l l l l l l l l l l α α α α l l l l l l l l l l l μ l l μ l μ l l μ l l μ l l l μ l l l l l l l μ l β l l μ l l l l α l l μ l l
More informationMicrosoft Word - ■3中表紙(2006版).doc
18 Annual Report on Research Activity by Faculty of Medicine, University of the Ryukyus 2006 FACULTY OF MEDICINE UNIVERSITY OF THE RYUKYUS α αγ α β α βγ β α β α β β β γ κα κ κ βγ ε α γδ β
More informationLightブログ_Mikata.qxd
46 Ω 1 3 2 15 Ω 47 6 4 5 7 5 CONTENTS 4 6 8 1 2 3 4 1 12 14 16 18 20 5 6 7 8 9 10 11 2 22 24 26 28 30 34 36 12 38 40 2 3 4 13 42 20 58 14 44 21 60 15 16 17 18 19 46 48 50 52 54 22 23 24 25 64 66 68 72
More information330
330 331 332 333 334 t t P 335 t R t t i R +(P P ) P =i t P = R + P 1+i t 336 uc R=uc P 337 338 339 340 341 342 343 π π β τ τ (1+π ) (1 βτ )(1 τ ) (1+π ) (1 βτ ) (1 τ ) (1+π ) (1 τ ) (1 τ ) 344 (1 βτ )(1
More informationPage
Page Page 1 3 4 M&A DCF NPV 1-1 BIS 1-3 1-2 5 6 1-3 2 2 0 200 010 2-1 A B B A B 7 8 Coffee Break CAPM Capital Asset Pricing model 3 IRR NPV EVA BS PL 9 2 ROA 3-1 EBIT Earnings Before Interest,Taxes) 3-2
More informationuntitled
Y = Y () x i c C = i + c = ( x ) x π (x) π ( x ) = Y ( ){1 + ( x )}( 1 x ) Y ( )(1 + C ) ( 1 x) x π ( x) = 0 = ( x ) R R R R Y = (Y ) CS () CS ( ) = Y ( ) 0 ( Y ) dy Y ( ) A() * S( π ), S( CS) S( π ) =
More informationuntitled
Global Quantitative Research / -2- -3- -4- -5- 35 35 SPC SPC REIT REIT -6- -7- -8- -9- -10- -11- -12- -13- -14- -15- -16- -17- 100m$110-18- Global Quantitative Research -19- -20- -21- -22- -23- -24- -25-
More informationTaro10-最終報告書本文編.jtd
2000 3 1996 11 11 2001 http://www.fsa.go.jp/p_mof/big-bang/bb1.htm Free 1,200 Fair Global iv http://www.fsa.go.jp/p_mof/big-bang/bb7.htm ) IASInternational Accounting Standards management news http://www.asahiaudit.or.jp/b_info/letter/05/01.html
More information日本分子第4巻2号_10ポスター発表.indd
JSMI Report 62 63 JSMI Report γ JSMI Report 64 β α 65 JSMI Report JSMI Report 66 67 JSMI Report JSMI Report 68 69 JSMI Report JSMI Report 70 71 JSMI Report JSMI Report 72 73 JSMI Report JSMI Report 74
More information基礎数学I
I & II ii ii........... 22................. 25 12............... 28.................. 28.................... 31............. 32.................. 34 3 1 9.................... 1....................... 1............
More information2002 12 2 1. 2002 8 2. 3. 4. 5. 2002 12 2 1 2 2 2 2 3 3 5 8 11 12 15 17 19 24 24 25 27 2002 8 1 2 16 2004 3 31 17 2005 3 30 16 4 1 17 4 1 1 3 1 3 1 2 1 2002 8 1999 2 3 2 1 2 2 2 3 2 3 3 2 4 1 4 3 2 2
More information24.15章.微分方程式
m d y dt = F m d y = mg dt V y = dy dt d y dt = d dy dt dt = dv y dt dv y dt = g dv y dt = g dt dt dv y = g dt V y ( t) = gt + C V y ( ) = V y ( ) = C = V y t ( ) = gt V y ( t) = dy dt = gt dy = g t dt
More informationROE
26 49 41 26 1,074 159 3 1,074 1,200 26 10 10 11 10 589 54.8% 159 26 10 10 11 10 86 54.1% 26... 1... 2... 2... 2... 3... 5... 6... 6... 7 ROE... 9... 10... 11... 11... 13... 14... 14... 15... 15... 16...
More information467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 485 486 487 488 489 490 B =(1+R ) B +G τ C C G τ R B C = a R +a W W ρ W =(1+R ) B +(1+R +δ ) (1 ρ) L B L δ B = λ B + μ (W C λ B )
More information本文/もくじ(表2)
NO. 32 1 2 4 6 10 12 14 18 20 22 24 27 29 30 33 34 39 41 42 43 44 45 46 1 2 3 4 5 6 7 8 9 10 11 12 13 κ βα 14 15 µκδ µ κ κ 16 17 18 19 α 20 21 22 23 24 25 26 Nature Nature 2001 ; 413 : 379 380 27 28 29
More information第89回日本感染症学会学術講演会後抄録(I)
! ! ! β !!!!!!!!!!! !!! !!! μ! μ! !!! β! β !! β! β β μ! μ! μ! μ! β β β β β β μ! μ! μ!! β ! β ! ! β β ! !! ! !!! ! ! ! β! !!!!! !! !!!!!!!!! μ! β !!!! β β! !!!!!!!!! !! β β β β β β β β !!
More information13 9 11 7 3 20
- 1 - 13 9 11 7 3 20 Point Point Point 1 2-1 - - 2 - - 3 - 1-4 - 2 3-5 - 1 2 3-6 - 1 2-7 - 3 4 5 6-8 - 1 2-9 - 1 2-10 - - 11 - - 12 - - 13 - 1 2-14 - 3 4 5 6 7-15 - 8-16 - - 17 - 1-18 - 2 1 2 3-19
More informationa a b a b c d e R c d e A a b e a b a b c d a b c d e f a M a b f d a M b a b a M b a M b M M M R M a M b M c a M a R b A a b b a CF a b c a b a M b a b M a M b c a A b a b M b a A b a M b C a M C a M
More informationron04-02/ky768450316800035946
β α β α β β β α α α Bugula neritina α β β β γ γ γ γ β β γ β β β β γ β β β β β β β β! ! β β β β μ β μ β β β! β β β β β μ! μ! μ! β β α!! β γ β β β β!! β β β β β β! β! β β β!! β β β β β β β β β β β β!
More information/ IR URL: 1
2005428 0 1. 2004 /2005 2. 2007 3. IR URL:http://www.tokyo-gas.co.jp/IR/ir_j.html 1 2004 * *04 18+ 1 52+ 1 2 3 840 1,328 1,453 11,907 FY04-4 +16 +25 +431 FY03 +393 +87.7 +18 +1.3-69 -4.6 +389 +3.4 * 04
More informationuntitled
21 H22 H20 H19 H20 H19 H21 H21 H17 H21 L=650m W=16m H21 L=355m H19 L=770m 15 8 1 (1) 42 118,607.62 118,606.34 1.28 18,748.35 18,748.31 0.04 2,845.58 2,845.48 0.10 1.42 40 40 18.89 0.65 1.44 20.98
More information4
4 5 6 7 + 8 = ++ 9 + + + + ++ 10 + + 11 12 WS LC VA L WS = LC VA = LC L L VA = LC L VA L 13 i LC VA WS WS = LC = VA LC VA VA = VA α WS α = VA VA i WS = LC VA i t t+1 14 WS = α WS + WS α WS = WS WS WS =
More informationPage
Page Page 1 BIS 200012 2 10 1-2 20003 3 4 1-1 1-2 * BIS CF CF CF PLAN DO BSPL BSPL SEE BS PL 5 6 1-3 PLAN DO SEE PLAN DO SEE PLAN DO SEE PLAN DO SEE BSPL BS PL 4 1-4 7 Coffee Break 2 BS PL CF) PLANDO SEE
More information<312D322D30348BE08BE28EEC2E696E6464>
57 連 体 修 飾 構 造 における 主 格 助 詞 の の 変 化 1.はじめに 1 2. 問 題 の 所 在 2 1 2 4 HERSETEC, 1, 2 (2007), 57 72 58 1 2 3 4 2 4 1 2 2 1955 3 3. 中 古 語 の 連 体 構 造 における 主 格 助 詞 の 1 2 59 3 1 195 55 1975 1978 1975 1978 1955 5
More informationA9R799F.tmp
!!!!! !!! " !!! ! "!!" " " ! ! " "!! "! " "!! !! !!! !!! ! !!!!! α ! "α!! "!! ! "α!! !! " " ! "! β ! ! "β " "! " " ! α λ !!!! ! """ ""! ! "!β"!!" ! ! "" ""! "!! !!!! ! " !! ! ! !"! "!! " ! ! α"!
More information0.,,., m Euclid m m. 2.., M., M R 2 ψ. ψ,, R 2 M.,, (x 1 (),, x m ()) R m. 2 M, R f. M (x 1,, x m ), f (x 1,, x m ) f(x 1,, x m ). f ( ). x i : M R.,,
2012 10 13 1,,,.,,.,.,,. 2?.,,. 1,, 1. (θ, φ), θ, φ (0, π),, (0, 2π). 1 0.,,., m Euclid m m. 2.., M., M R 2 ψ. ψ,, R 2 M.,, (x 1 (),, x m ()) R m. 2 M, R f. M (x 1,, x m ), f (x 1,, x m ) f(x 1,, x m ).
More information204 / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January 2016 047
9 π 046 Vol.69-1 January 2016 204 / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January 2016 047 β γ α / α / 048 Vol.69-1 January 2016 π π π / CHEMISTRY & CHEMICAL INDUSTRY Vol.69-1 January 2016 049 β 050 Vol.69-1
More informationEV EV 4 階 3 階 2 階 EV EV WC EV 自 販 機 喫 煙 所 WC WC WC WC 喫 煙 所 自 販 機 1 階 E 棟 D 棟 ( 工 事 中 ) STUDENT PLAZA 吹 抜 WC WC 受 付 WC WC EV EV WC EV 4 階 3 階 2 階 EV 自 販 機 EV 自 販 機 喫 煙 所 C 棟 A 棟 2 階 1 階 2 階 1 階 H 棟 WC
More information第88回日本感染症学会学術講演会後抄録(III)
!!!! β! !!μ μ!!μ μ!!μ! !!!! α!!! γδ Φ Φ Φ Φ! Φ Φ Φ Φ Φ! α!! ! α β α α β α α α α α α α α β α α β! β β μ!!!! !!μ !μ!μ!!μ!!!!! !!!!!!!!!! !!!!!!μ! !!μ!!!μ!!!!!! γ γ γ γ γ γ! !!!!!! β!!!! β !!!!!! β! !!!!μ!!!!!!
More information